Several countries have said they will resume AstraZeneca vaccinations after Europe's medical regulator said the jab is "safe and effective" and not associated with a higher blood clot risk after days of commotion around the shot. For more on this we’re joined now by Kingston Mills, Professor of Experimental Immunology at Trinity College Dublin and also David Salisbury, Former Director of Immunisation at the UK’s Department of Health and Associate Fellow of Chatham House’s Global Health Programme.
